Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens

Abstract excerpt

<h4>Background: </h4> Protein-conjugate capsular polysaccharide vaccines can potentially control invasive meningococcal disease (IMD) caused by five (A, C, W, X, Y) of the six IMD-associated serogroups.  Concerns raised by immunological similarity of the serogroup B capsule to human neural cell carbohydrates, meant that ‘serogroup B substitute’ vaccines target more variable subcapsular protein antigens.  A...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacterial Infections and Vaccines
• Share to Pneumonia and Respiratory Infections
• Share to RNA and protein synthesis mechanisms